SCHEMBL6955856

SCHEMBL6955856

CCN1c2ncc(COc3cccc(N)c3)cc2C(=O)N(C)c2ccc(Cl)nc21

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.42
CYP2C9 P11712 3/20 0.42
CYP2C19 P33261 3/20 0.42
CYP1A2 P05177 3/20 0.42
MAOB P27338 2/20 0.37
CYP11B1 P15538 3/20 0.36
CYP11B2 P19099 3/20 0.36
CYP2D6 P10635 2/20 0.36
APP P05067 1/20 0.35
TP53 P04637 1/20 0.34
BRD4 O60885 1/20 0.33
GRM2 Q14416 1/20 0.33
GRM5 P41594 1/20 0.32
DCLK1 O15075 1/20 0.32
MAPK7 Q13164 1/20 0.32
LRRK2 Q5S007 1/20 0.32
ABL1 P00519 1/20 0.32
CNR2 P34972 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6957500 0.90 CYP3A4 (0.43) CYP3A4CYP2C9CYP2C19CYP1A2MAOB
SCHEMBL6951069 0.90 CYP3A4 (0.47) CYP3A4CYP2C9CYP2C19CYP1A2CYP11B1
SCHEMBL6959409 0.89 CYP3A4 (0.53) CYP3A4CYP2C9CYP2C19CYP1A2MAOB
SCHEMBL6965904 0.88 CYP3A4 (0.45) CYP3A4CYP2C9CYP2C19CYP1A2MAOB
SCHEMBL6954120 0.87 CYP3A4 (0.53) CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL6964778 0.86 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19CYP1A2CYP11B1
SCHEMBL6955525 0.86 CYP3A4 (0.46) CYP3A4CYP2C9CYP2C19CYP1A2MAOB
SCHEMBL6964026 0.85 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19CYP1A2CYP11B1
SCHEMBL6967095 0.85 CYP3A4 (0.46) CYP3A4CYP2C9CYP2C19CYP1A2MAOB
SCHEMBL6956935 0.85 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19CYP1A2MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0767172-B1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 2003-03-26 EP claimed
EP-0767172-A1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1997-04-09 EP claimed
EP-0767172-B1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 2003-03-26 EP disclosed
US-5705499-A VIRICIDES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1998-01-06 US disclosed
EP-0767172-A1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1997-04-09 EP disclosed